This document specifies information model of representation for quality control of Chinese patent drugs by defining a set of domain constraints of sanctioned characteristics each composed of a relationship and an applicable information model in order to represent the quality control of manufacturing process of Chinese materia medica. It is applicable to the quality supervision and management of manufacturing process of Chinese materia medica. Japanese KAMPO medicine is out of the scope.
Status: Under developmentPublication date: 2023-06
Technical Committee: ISO/TC 215 Health informatics
- ICS :
- 35.240.80 IT applications in health care technology
This standard contributes to the following Sustainable Development Goal:
ISO/TS 5044Stage: 60.00 (Under publication)
Got a question?
Check out our FAQs
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)
Keep up to date with ISO
Sign up to our newsletter for the latest news, views and product information.